日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of Frequency of Prospekta Administration: Anxiolytic Effect in Wistar Rats

Prospekta给药频率的影响:对Wistar大鼠的抗焦虑作用

Svitkin, Kirill; Morozova, Elizaveta; Krasheninnikova, Anna; Kardash, Elena; Ganina, Ksenia; Emelyanova, Alexandra; Tarasov, Sergey; Epstein, Oleg

Pro-cognitive efficacy of Prospekta in a rat model of age-associated cognitive impairment.

Prospekta 在老年相关认知障碍大鼠模型中的促认知功效

Kardash Elena, Petrova Nataliya, Ganina Ksenia, Tarasov Sergey, Epstein Oleg

Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT

胃肠道功能性疾病及其交叉疾病的发病机制研究:俄罗斯回顾性观察项目COMFORT的结果

Ivashkin, Vladimir T; Poluektova, Elena A; Glazunov, Alexey B; Putilovskiy, Mikhail A; Epstein, Oleg I

Vascular cognitive impairment: pathophysiological mechanisms, insights into structural basis, and perspectives in specific treatments

血管性认知障碍:病理生理机制、结构基础解析及具体治疗展望

Parfenov, Vladimir A; Ostroumova, Olga D; Ostroumova, Tatiana M; Kochetkov, Alexey I; Fateeva, Victoria V; Khacheva, Kristina K; Khakimova, Gulnara R; Epstein, Oleg I

Dose-Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light-Dark Test in Mice

小鼠光暗试验中S100蛋白和1型大麻素受体释放活性形式的抗体剂量反应效应

Kardash, Elena V; Ertuzun, Irina A; Khakimova, Gul'nara R; Kolyadin, Andrey N; Tarasov, Sergey A; Wagner, Stéphanie; Andriambeloson, Emile; Ivashkin, Vladimir T; Epstein, Oleg I

Efficacy and safety of Afalaza in men with symptomatic benign prostatic hyperplasia at risk of progression: a multicenter, double-blind, placebo-controlled, randomized clinical trial

Afalaza治疗有症状良性前列腺增生且有进展风险的男性患者的疗效和安全性:一项多中心、双盲、安慰剂对照、随机临床试验

Pushkar, Dmitry; Vinarov, Andrey; Spivak, Leonid; Kolontarev, Konstantin; Putilovskiy, Mikhail; Andrianova, Elena; Epstein, Oleg

An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular Liabilities

一种口服有效的BACE1抑制剂,可在不产生心血管副作用的情况下显著降低中枢神经系统Aβ水平。

Cheng, Yuan; Brown, James; Judd, Ted C; Lopez, Patricia; Qian, Wenyuan; Powers, Timothy S; Chen, Jian Jeffrey; Bartberger, Michael D; Chen, Kui; Dunn, Robert T 2nd; Epstein, Oleg; Fremeau, Robert T Jr; Harried, Scott; Hickman, Dean; Hitchcock, Stephen A; Luo, Yi; Minatti, Ana Elena; Patel, Vinod F; Vargas, Hugo M; Wahl, Robert C; Weiss, Matthew M; Wen, Paul H; White, Ryan D; Whittington, Douglas A; Zheng, Xiao Mei; Wood, Stephen

Novel approach to activity evaluation for release-active forms of anti-interferon-gamma antibodies based on enzyme-linked immunoassay.

基于酶联免疫测定的抗干扰素γ抗体释放活性形式的活性评价新方法

Gavrilova Elena S, Bobrovnik Sergey A, Sherriff Gordon, Myslivets Andrey A, Tarasov Sergey A, Epstein Oleg I

The novel oral drug Subetta exerts an antidiabetic effect in the diabetic Goto-Kakizaki rat: comparison with rosiglitazone

新型口服药物Subetta在糖尿病Goto-Kakizaki大鼠模型中具有抗糖尿病作用:与罗格列酮的比较

Bailbé, Danielle; Philippe, Erwann; Gorbunov, Evgeniy; Tarasov, Sergey; Epstein, Oleg; Portha, Bernard

A Comparison of the Dynamics of S100B, S100A1, and S100A6 mRNA Expression in Hippocampal CA1 Area of Rats during Long-Term Potentiation and after Low-Frequency Stimulation

大鼠海马CA1区S100B、S100A1和S100A6 mRNA表达在长期增强作用和低频刺激后的动态变化比较

Lisachev, Pavel D; Shtark, Mark B; Sokolova, Olga O; Pustylnyak, Vladimir O; Salakhutdinova, Mary Yu; Epstein, Oleg I